LightPath Technologies, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2023, with comparison to fiscal 2022. The request metadata says “2022 Q4,” but the filing covers fiscal 2023; quarterly figures below refer to the three months ended June 30, 2023.
Business context
LightPath designs and manufactures precision molded optics, infrared optics and optical assemblies, serving markets including defense, industrial, medical, telecommunications and automotive. Its strategy is shifting from component sales toward engineered optical solutions and longer-term customer supply programs. Manufacturing facilities are in Orlando, Florida; Riga, Latvia; and Zhenjiang, China.
Financial performance and liquidity
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $32.9 million | $35.6 million |
| Gross margin | $11.1 million; 34% of revenue | $11.8 million; 33% of revenue |
| Operating loss | $3.6 million | $2.6 million |
| Net loss | $4.0 million; $0.13 per share | $3.5 million; $0.13 per share |
| EBITDA, non-GAAP | Loss of $355,000 | Income of $1.2 million |
| Cash from operations | Used $2.8 million | Provided $1.5 million |
| Capital expenditures | $3.1 million | $1.6 million |
At June 30, 2023, working capital was $14.9 million. Cash, cash equivalents and restricted cash totaled $7.1 million, including $2.5 million pledged as loan collateral; cash and cash equivalents excluding restricted cash were $4.7 million. Total loans payable were approximately $2.6 million, including a $2.2 million BankUnited term loan. The term loan bears interest at 8.25% as of year-end and matures December 31, 2024. Operating lease liabilities were $9.4 million.
Changes versus the prior year
- Revenue fell 7%. Infrared revenue declined 11% to $16.7 million and PMO revenue declined 11% to $13.4 million; specialty revenue rose 54% to $2.8 million.
- Gross margin percentage improved to 34% from 33%, reflecting cost and operational improvements, although gross margin dollars declined with revenue.
- Net loss increased by about $505,000; operating loss worsened by about $927,000. Lower tax expense partly offset the deterioration.
- Operating cash flow swung to a $2.8 million use, driven mainly by higher receivables and inventory. Average inventory days rose to 125 from 118, and average receivable days rose to 58 from 54.
- The company raised approximately $9.2 million net in a January 2023 public offering of 9.1 million shares. Weighted-average shares outstanding increased to 31.6 million from 27.0 million.
- Year-end backlog was $21.7 million, up 22% year over year but down 19% from the prior quarter.
Outlook, commentary and risks
- Management expects growth primarily from infrared products, engineered solutions and assemblies, and sees opportunity in its BD6 and other germanium-alternative materials. It does not expect significant near-term growth in visible PMO products. No quantified revenue or earnings guidance is provided.
- Management says it expects improved operating cash flow as certain non-recurring payables are behind it, while targeting sales growth, better margins and working-capital management. The filing does not provide a clear quantified forecast for these outcomes.
- The company is discussing refinancing its BankUnited term loan before its December 2024 maturity; success and acceptable terms are not assured. Failure to refinance could require equity or other financing, cost reductions, or reduced capital spending.
- China announced export licensing requirements for germanium in July 2023. LightPath’s Chinese suppliers had applied for licenses but had not received them by the filing date, creating supply and cost uncertainty. Inflation, limited-source suppliers, geopolitical disruption and weaker Chinese demand are additional risks.
- Three customers represented 24% of FY2023 revenue, down from 35% in FY2022. International sales were 50% of revenue. More than 25% of cash, cash equivalents and restricted cash was held by foreign subsidiaries, and some funds may be difficult to repatriate promptly.
- In July 2023, after fiscal year-end, LightPath acquired Visimid Technologies for $1.0 million cash, $1.55 million in restricted stock, $150,000 of assumed bank debt and a contingent earnout. Visimid adds thermal imaging, night-vision and camera-core engineering capabilities.
- Unusual items include approximately $140,000 in FY2023 acquisition costs, temporary outsourcing costs during Orlando facility construction, and prior-year income of $210,000 from reversing a potential China-related liability. China-related severance payments were made in the first half of FY2023; related legal proceedings remain pending, with further legal costs expected but anticipated to be lower.
- Management reported effective disclosure controls and internal control over financial reporting. The independent auditor issued an unqualified opinion on the financial statements; it did not provide an audit opinion on internal controls.
Investor verification priorities
- Track germanium export-license approvals, alternative material supply, and any resulting production delays or cost increases.
- Verify progress and terms for refinancing the BankUnited loan, including cash-collateral releases and exit fees.
- Monitor cash conversion, receivables, inventory and backlog conversion into shipments and revenue.
- Assess whether infrared and engineered-solutions growth offsets weakness in China and PMO demand, and confirm Visimid’s integration, contribution and contingent earnout conditions.
- Review customer concentration, foreign cash accessibility, and the status and financial exposure of the remaining China litigation.